Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:46 PM
Ignite Modification Date:
2025-12-24 @ 5:46 PM
NCT ID:
NCT02749968
Eligibility Criteria:
Inclusion Criteria:
* Anticipated length of stay of at least 72 hours
* Blunt chest wall trauma with two or more rib or sternal fractures
* Demonstrated ability to achieve \> 50% predicted inspiratory capacity based on ideal body weight using IS within the first 24 hours of admission
Exclusion Criteria:
* Known allergy to bupivacaine
* Respiratory failure requiring intubation within 24 hours prior to enrollment
* Known or suspected atrioventricular nodal blockade process requiring cardiology evaluation or pacemaker placement
* Hemodynamic instability (defined as new intravenous vasopressor or inotrope requirement or mean arterial pressure \< 55 mmHg)
* Signs of active myocardial ischemia or non-ST elevation MI
* \> 20 rib fractures
* Weight \< 50 kg or \> 150 kg
* Pregnancy
* Incarceration
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02749968
Study Brief:
Protocol Section:
NCT02749968